HALOZYME THERAPEUTICS, INC. Annual Earnings Per Share, Basic in USD/shares from 2015 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Halozyme Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2015 to 2023.
  • Halozyme Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was 0.73 USD/shares, a 28.1% increase year-over-year.
  • Halozyme Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was 2.61 USD/shares, a 50% increase year-over-year.
  • Halozyme Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was 2.13 USD/shares, a 43.9% increase from 2022.
  • Halozyme Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was 1.48 USD/shares, a 48.3% decline from 2021.
  • Halozyme Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was 2.86 USD/shares, a 201% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.13 +$0.65 +43.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $1.48 -$1 -48.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $2.86 +$1.91 +201% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $0.95 +$1.45 Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $1 +$0.06 +10.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-22
2018 -$1 -$1 -222% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 $0.46 +$1.27 Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 -$1 -$1 -224% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-21
2015 $0 Jan 1, 2015 Dec 31, 2015 10-K 2018-02-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.